EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

High-dose intravenous methylprednisolone is effective in subacute thyroiditis unresponsive to oral steroids

Simone Rodolfi, Guia Maria Vannucchi, Michela Perrino, Carla Colombo, Danila Covelli, Luca Persani iD, Laura Fugazzola iD, Irene Campi iD

European Thyroid Journal · 01.04.2026 · 15 (2)

DOI: 10.1530/etj-25-0346 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Thyroid Journal, online erschienen am 13.03.2026. Verfasst von Simone Rodolfi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy. Hauptthemen laut MEDLINE: Methylprednisolone, Thyroiditis, Subacute, Anti-Inflammatory Agents. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Subacute thyroiditis (SAT) relapsing or refractory to standard of care oral prednisone (OP) therapy is rare, but affected patients experience significant discomfort due to prolonged and uncontrolled neck pain. Here, we report the efficacy of high-dose intravenous methylprednisolone (IVMP) therapy in the treatment of such cases.

Methods

In this pilot study, we included 14 patients diagnosed with SAT in the period 2014–2024, in a single center. Therapy consisted of 500 mg of IVMP, divided into two weekly infusions and titrated down based on clinical response. Thyroid function tests, thyroid ultrasound, and inflammatory markers were assessed at baseline and throughout the follow-up up to 3–6 months after IVMP discontinuation.

Results

At baseline, 4 and 10 patients had thyrotoxicosis or were euthyroid, respectively. The median (IQR) duration of treatment was 26 days (21–38). At the end of the treatment, we observed a complete clinical, ultrasonographic, and biochemical response in twelve patients (86%), whereas thirteen (93%) had immediate resolution of neck pain and thyrotoxicosis. Only one patient did not improve at the end of IVMP protocol, and she was the only one experiencing a delayed remission with persistent hypothyroidism. Mild grade 1 and 2 adverse events (hyperglycemia, arterial hypertension, and neutrophilia) occurred in 8 out of 14 patients.

Conclusion

IVMP therapy resulted in a rapid clinical and ultrasonographic improvement in most patients with relapsing SAT unresponsive to oral steroids. This response allowed for a shorter treatment duration, with good tolerability, minimal adverse events, and a low incidence of hypothyroidism during follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethylprednisoloneThyroiditis, SubacuteAnti-Inflammatory AgentsHumansFemaleMalePilot ProjectsMiddle AgedAdultAdministration, OralTreatment OutcomeAgedPrednisoneAdministration, Intravenous

Stichwörter der Autor:innen

corticosteroid adverse eventsintravenous methylprednisolonepermanent hypothyroidismsubacute thyroiditisthyrotoxicosis

Substanzen

MethylprednisolonePrednisoneAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
  • Department of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy.
  • Department of Endocrine and Metabolic Diseases, Endocrine Oncology Unit, IRCCS Istituto Auxologico Italiano, Milan, Italy.
  • Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
  • ASST Bergamo Est, Seriate, Italy.
  • Endocrinology Unit ASST Santi Paolo e Carlo, Milan, Italy.

ORCID-Profile: Luca Persani, Laura Fugazzola, Irene Campi

Zitieren

APA

Rodolfi, S., Vannucchi, G. M., Perrino, M., Colombo, C., Covelli, D., Persani, L., Fugazzola, L., & Campi, I. (2026). High-dose intravenous methylprednisolone is effective in subacute thyroiditis unresponsive to oral steroids. European Thyroid Journal, 15(2). https://doi.org/10.1530/etj-25-0346

Vancouver

Rodolfi S, Vannucchi GM, Perrino M, Colombo C, Covelli D, Persani L, et al. High-dose intravenous methylprednisolone is effective in subacute thyroiditis unresponsive to oral steroids. European Thyroid Journal. 2026;15(2). doi:10.1530/etj-25-0346

BibTeX
@article{Rodolfi2026,
  author = {Rodolfi, Simone and Vannucchi, Guia Maria and Perrino, Michela and Colombo, Carla and Covelli, Danila and Persani, Luca and Fugazzola, Laura and Campi, Irene},
  title = {High-dose intravenous methylprednisolone is effective in subacute thyroiditis unresponsive to oral steroids},
  journal = {European Thyroid Journal},
  year = {2026},
  volume = {15},
  number = {2},
  doi = {10.1530/etj-25-0346}
}
Kostenlos starten →